MAPT and Alzheimer disease: Core CSF biomarkers for AD include levels of Aβ42, total tau (t-tau), and phosphorylated tau (p-tau) [56,57], which are the principal elements of amyloid plaques and tau tangles, the defining characteristics of AD.